BHC(SH:600721) Zheng Quan Shi Bao Wang·2026-01-13 10:12Group 1 - Baihua Pharmaceutical (600721) experienced a trading halt today with a turnover rate of 27.87%, total transaction amounting to 1.085 billion yuan, and a price fluctuation of 9.65% [2] - The stock was listed on the Shanghai Stock Exchange due to its turnover rate, with a net buying amount of 19.2572 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 153 million yuan, with a buying amount of 86.1071 million yuan and a selling amount of 66.8499 million yuan, resulting in a net buying of 19.2572 million yuan [2] Group 2 - In the last six months, the stock has appeared on the trading list seven times, with an average price drop of 2.29% the next day and an average increase of 0.46% over the following five days [2] - Today's main capital inflow for the stock was 163 million yuan, with a large single net inflow of 134 million yuan and a net inflow of 28.9265 million yuan from large orders [2] - Over the past five days, the main capital has seen a net outflow of 80.2895 million yuan [2] Group 3 - For the first three quarters of 2025, the company reported a total operating income of 299 million yuan, representing a year-on-year growth of 2.74%, and a net profit of 32.6742 million yuan, reflecting a year-on-year increase of 36.41% [3] - The top buying brokerage seat was CITIC Securities, Shanghai Jing'an District, with a buying amount of 21.4054 million yuan, while the top selling seat was GF Securities, Shanghai Xiuyan Road, with a selling amount of 20.0702 million yuan [3][4]